Insider Trading History of Bukofzer Stan

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Bukofzer Stan since 2016. The trader's CIK number is 1663041. At the time of the last reporting, Bukofzer Stan was the Chief Medical Officer of Assertio Therapeutics, Inc. (stock ticker symbol ASRT). Also see all insider trading activities at Assertio Therapeutics, Inc.

Note that in the past Bukofzer Stan also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Assertio Therapeutics, Inc (ASRT) by Bukofzer Stan

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 ASRT 0 $0 0 $0 52,958 $0
2019 ASRT 13,000 $33,116 0 $0 25,370 $0

Yearly summary of insider trading at Tranzyme Inc (OCRX) by Bukofzer Stan

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 OCRX 2,500 $6,597 0 $0 0 $0


Insider trading activities at 2 companies by Bukofzer Stan:

1. Assertio Therapeutics, Inc (ASRT)

2. Tranzyme Inc (OCRX)

Table 1. Insider trading of Assertio Therapeutics, Inc (ASRT) by Bukofzer Stan

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-04-02 ASRT Option Ex 25,370 .00 0
2020-02-12 ASRT Option Ex 27,588 .00 0
2019-08-13 ASRT Buy 4,000 1.56 6,228
2019-08-13 ASRT Buy 4,000 1.56 6,228
2019-04-02 ASRT Option Ex 25,370 .00 0
2019-03-14 ASRT Buy 5,000 4.13 20,660

Table 2. Insider trading of Tranzyme Inc (OCRX) by Bukofzer Stan

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-10-13 OCRX Buy 2,500 2.64 6,597

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bukofzer Stan (Chief Medical Officer of Assertio Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.